Investigators have established a protein that can help predict the initial signs of ovarian cancer which starts in the womanly organs that produce eggs (ovaries) and is typically hard to diagnose because it expands virtually unseen into the abdominal cavity. If predicted early adequate, the fatal cancer in the ovaries react well to chemotherapy. The researchers though have further conveyed that, once it increases, it turns out into opposed to chemotherapy and is far more probable to kill. Ahmed, Professor at the Oxford University has also conveyed that, ovarian cancer can be untraceable for up to four years and only a third of people with the cancer get near the beginning diagnosis.
The researches established that, levels of a protein called SOX2 are much superior in the fallopian tubes of people with ovarian cancer. Ahmed has also further conveyed that, a test for SOX2 could not only help predict cancers premature but in some cases would allow us to notice a tumor previous to it becomes cancerous. Additional, SOX2 levels is also superior in some people who are at elevated risk of rising ovarian cancer such as those with inherited mutations in BRCA1 and BRCA2 genes. Untimely treatment enormously improves the odds for patients, so early detection is necessary.